Ranbaxy Will Launch Generic Valtrex After GlaxoSmithKline Patent Expires In 2009
This article was originally published in The Pink Sheet Daily
Executive Summary
Indian firm also licensed two process patents related to the herpes virus treatment after the firms resolved a patent infringement dispute.
You may also be interested in...
Ranbaxy/GSK Partnership Yields First Drug Candidate
Ranbaxy will develop a respiratory disease candidate through proof of concept under an expanded discovery agreement inked with GSK in February.
Generic Valtrex Launch Likely Delayed Pending Resolution Of GSK/Ranbaxy Suit
GlaxoSmithKline says it will file a motion for preliminary injunction to block Ranbaxy from launching generic valacyclovir.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.